Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions

Simple item page
dc.contributor.authorZitha, Eddyen_ZA
dc.contributor.authorChiliza, Bonginkosien_ZA
dc.contributor.authorMuloiwa, Rudzanien_ZA
dc.contributor.authorLehloenya, Rannakoeen_ZA
dc.date.accessioned2014-07-28T09:01:16Z
dc.date.available2014-07-28T09:01:16Z
dc.date.issued2014-07
dc.date.updated2014-07-18T11:03:13Z
dc.descriptionCITATION: Zitha, E., Chiliza, B., Muloiwa, R. & Lehloenya, R. 2014. Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions. Clinical and Translational Allergy, 4(Suppl 3):P95, doi:10.1186/2045-7022-4-S3-P95.en_ZA
dc.descriptionThe original publication is available at http://www.ctajournal.com/content/4/S3/P95en_ZA
dc.description.abstractBackground Little is known on the short-term or medium-term psychological and psychiatric sequelae following Stevens Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and drug reaction with eosinophilia and systemic symptoms (DRESS). Based on this we did a prospective study designed to assess anxiety and depression in patients with severe cutaneous adverse drug reactions by indicating higher Hospital anxiety and depression scale (HADS).en_ZA
dc.description.versionPublishers' Versionen_ZA
dc.format1 page
dc.identifier.citationZitha, E., Chiliza, B., Muloiwa, R. & Lehloenya, R. 2014. Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions. Clinical and Translational Allergy, 4(Suppl 3):P95, doi:10.1186/2045-7022-4-S3-P95.en_ZA
dc.identifier.issn2045-7022 (online)en_ZA
dc.identifier.otherdoi:10.1186/2045-7022-4-S3-P95en_ZA
dc.identifier.urihttp://hdl.handle.net/10019.1/95512
dc.language.isoen_ZAen_ZA
dc.publisherBioMed Centralen_ZA
dc.rights.holderEddy Zitha et al.; licensee BioMed Central Ltd.en_ZA
dc.subjectDrugs -- Side effects -- Psychological aspectsen_ZA
dc.titleIncidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactionsen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
2045-7022-4-S3-P95.xml
Size:
4.37 KB
Format:
Extensible Markup Language
Description:
Download
Thumbnail Image
Name:
2045-7022-4-S3-P95.pdf
Size:
199.44 KB
Format:
Adobe Portable Document Format
Description:
Download article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.95 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (Psychiatry)